Breaking Finance News

Liberum Capital announced UDG Healthcare PLC (LON:UDG), upholding its stock price target at 884.00GBX today

In a report released on 11/15/2017 Liberum Capital hold steady the stock price target of UDG Healthcare PLC (LON:UDG) from 884.00GBX to 884.00GBX reporting a possible upside of 0%.

Previously on 11/09/2017, Numis released a statement about UDG Healthcare PLC (LON:UDG) held steady the target price at 765.00GBX. At the time, this indicated a possible downside of -0.17%.

Just yesterday UDG Healthcare PLC (LON:UDG) traded -0.27% lower at 0.00GBX. UDG Healthcare PLC’s 50-day moving average is 878.78GBX and its 200-day moving average is 827.03GBX. The last stock price is down 12.81% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.02% over the same time period. 387,692 shares of UDG traded hands, down from an average trading volume of 554,688

Recent Performance Chart

UDG Healthcare PLC (LON:UDG)

UDG Healthcare PLC has 52 week low of 612.00GBX and a 52 week high of 941.00GBX with a PE ratio of 11.38 and has a market capitalization of 0 GBX.

In addition to Liberum Capital reporting its stock price target, a total of 6 brokerages have issued a research note on the company. The average stock price target is 9.00GBX with 1 brokerage rating the stock a strong buy, 6 brokerages rating the stock a buy, 1 brokerage rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On UDG Healthcare PLC (LON:UDG)

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies. The Sharp Packaging Services segment is engaged in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries. The Supply Chain Services segment includes Aquilant, a provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors. It operates in approximately 23 countries and delivers services across 50 countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.